Medicare Enrolled

Dr. Matthew Seagle, FNP-BC

Nurse Practitioner - Family · Lincolnton, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1470 E GASTON ST, Lincolnton, NC 28092
7047357474
In practice since 2019 (6 years)
NPI: 1407402399 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seagle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seagle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Seagle

Dr. Matthew Seagle is a nurse practitioner - family in Lincolnton, NC, with 6 years of NPI registration. Based on federal Medicare data, Dr. Seagle performed 531 Medicare services across 266 unique beneficiaries.

Between the years covered by Open Payments, Dr. Seagle received a total of $15,440 from 61 pharmaceutical and/or device companies across 1155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Seagle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice ▲ Top 27% volume in NC $15,440 industry payments

Medicare Practice Summary

Medicare Utilization ↗
531
Medicare services
Top 27% in NC for nurse practitioner - family
266
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
121 $0 $2
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $51 $178
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
102 $62 $253
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
89 $6 $6
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
50 $8 $47
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
29 $104 $257
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
23 $2 $7
Respiratory virus detection test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses.
14 $49 $175
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,440
Total received (2021-2024)
Avg $3,860/year across 4 years
Top 1% in NC for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,155
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,440 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,650
2023
$3,879
2022
$3,721
2021
$4,190

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$512
ABBVIE INC.
$414
Novo Nordisk Inc
$366
PFIZER INC.
$239
Lilly USA, LLC
$237
Bayer Healthcare Pharmaceuticals Inc.
$211
Otsuka America Pharmaceutical, Inc.
$193
Astellas Pharma US Inc
$157
Tolmar, Inc.
$150
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Sumitomo Pharma America, Inc.
$134
GlaxoSmithKline, LLC.
$127
Azurity Pharmaceuticals, Inc.
$93
Axsome Therapeutics, Inc.
$89
IDORSIA PHARMACEUTICALS US INC
$78
Amgen Inc.
$58
Corcept Therapeutics
$54
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$53
Exact Sciences Corporation
$47
Phathom Pharmaceuticals, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$44
IRONSHORE PHARMACEUTICALS INC.
$32
Esperion Therapeutics, Inc.
$29
Lundbeck LLC
$26
Amneal Pharmaceuticals LLC
$25
Corium, LLC
$25
Novartis Pharmaceuticals Corporation
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$20
IRONWOOD PHARMACEUTICALS, INC
$20
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$2,198
AstraZeneca Pharmaceuticals LP
$1,492
ABBVIE INC.
$1,251
Kowa Pharmaceuticals America, Inc.
$913
Lilly USA, LLC
$858
Boehringer Ingelheim Pharmaceuticals, Inc.
$693
Amgen Inc.
$555
Takeda Pharmaceuticals U.S.A., Inc.
$537
Otsuka America Pharmaceutical, Inc.
$530
Bayer Healthcare Pharmaceuticals Inc.
$513
PFIZER INC.
$435
Clarus Therapeutics Inc.
$348
AbbVie Inc.
$305
GlaxoSmithKline, LLC.
$299
Tolmar, Inc.
$295
Astellas Pharma US Inc
$283
Bayer HealthCare Pharmaceuticals Inc.
$275
IDORSIA PHARMACEUTICALS US INC
$274
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$212
Biohaven Pharmaceutical Holding Company Ltd.
$211
Novartis Pharmaceuticals Corporation
$206
Sumitomo Pharma America, Inc.
$205
Janssen Pharmaceuticals, Inc
$194
Amarin Pharma Inc.
$182
Biohaven Pharmaceuticals, Inc.
$182
SANOFI-AVENTIS U.S. LLC
$174
Corcept Therapeutics
$162
Currax Pharmaceuticals LLC
$142
Antares Pharma, Inc.
$141
Azurity Pharmaceuticals, Inc.
$132
Axsome Therapeutics, Inc.
$124
Exact Sciences Corporation
$113
Teva Pharmaceuticals USA, Inc.
$89
Amneal Pharmaceuticals LLC
$80
Corium, LLC
$79
Lundbeck LLC
$75
Bausch Health US, LLC
$61
ITI, Inc.
$55
Esperion Therapeutics, Inc.
$52
Eisai Inc.
$49
Phathom Pharmaceuticals, Inc.
$46
Dexcom, Inc.
$38
IRONSHORE PHARMACEUTICALS INC.
$32
Radius Health, Inc.
$32
Noven Therapeutics, LLC
$31
FORTE BIO-PHARMA LLC
$31
Tris Pharma Inc
$29
Ironshore Pharmaceuticals Inc.
$26
Sunovion Pharmaceuticals Inc.
$25
Inari Medical, Inc.
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$20
IRONWOOD PHARMACEUTICALS, INC
$20
Mylan Specialty L.P.
$17
EISAI INC.
$16
Almatica Pharma LLC
$15
Ironwood Pharmaceuticals, Inc
$15
ARBOR PHARMACEUTICALS, INC.
$14
Adlon Therapeutics L.P.
$12
SCYNEXIS, Inc.
$12
Neos Therapeutics, LP
$12
Genentech USA, Inc.
$5
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · AIRSUPRA · AJOVY · APLENZIN · AREXVY · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aimovig · AirDuo Digihaler · Auvelity · Azstarys · BREZTRI · CAPLYTA · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · FARXIGA · FLOWTRIEVER CATHETER · GEMTESA · GRALISE · HORIZANT · Horizant · INVEGA SUSTENNA · JARDIANCE · JATENZO · JORNAY PM · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PREMARIN · PROLATE · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · S · SEGLENTIS · SOLIQUA 100/33 · STIOLTO RESPIMAT · Saxenda · Secuado · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Tymlos · UBRELVY · UNITHROID · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xelstrym · Xofluza · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in NC.

Looking for a nurse practitioner - family in Lincolnton?
Compare family nurse practitioners in the Lincolnton area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
465
Per 100K population
514.6
County median income
$78,490
Nearest hospital
ATRIUM HEALTH LINCOLN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Seagle is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NC), with low-engagement industry engagement in the top 1% of NC peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Seagle experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Seagle performed 121 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Seagle receive payments from pharmaceutical companies?
Yes. Dr. Seagle received a total of $15,440 from 61 companies across 1,155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seagle's costs compare to other family nurse practitioners in Lincolnton?
Dr. Seagle's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seagle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →